Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,849
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Long noncoding RNA PP7080 promotes hepatocellular carcinoma development by sponging mir-601 and targeting SIRT1

Weifang Songa Department of Pathophysiology, Fenyang College of Shanxi Medical University, Fenyang, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8143-6882View further author information
ORCID Icon,
Zhang Wenhuia Department of Pathophysiology, Fenyang College of Shanxi Medical University, Fenyang, ChinaView further author information
,
Yao Ruiqiangb Department of Clinical Medicine, Fenyang College of Shanxi Medical University, Fenyang, ChinaView further author information
,
Xinli Hua Department of Pathophysiology, Fenyang College of Shanxi Medical University, Fenyang, ChinaView further author information
,
Ting Shia Department of Pathophysiology, Fenyang College of Shanxi Medical University, Fenyang, ChinaView further author information
,
Meijiao Wanga Department of Pathophysiology, Fenyang College of Shanxi Medical University, Fenyang, ChinaView further author information
&
Haijuan Zhanga Department of Pathophysiology, Fenyang College of Shanxi Medical University, Fenyang, ChinaView further author information
 show all
Pages 1599-1610 | Received 30 Nov 2020, Accepted 17 Apr 2021, Published online: 06 May 2021

References

  • Saran U, Humar B, Kolly P, et al. Hepatocellular carcinoma and lifestyles. J Hepatol. 2016;64(1):203–214.
  • Wallace MC, Preen D, Jeffrey GP, et al. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015;9(6):765–779.
  • Klingenberg M, Matsuda A, Diederichs S, et al. Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017;67(3):603–618.
  • Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–159.
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
  • Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
  • Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–866.
  • Kong YW, Ferland-mccollough D, Jackson TJ, et al. microRNAs in cancer management. Lancet Oncol. 2012;13(6):e249–e258.
  • Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122–1143.
  • Wang Q, Huang Z, Ni S, et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. Plos One. 2012;7(9):e44398.
  • Ohdaira H, Nakagawa H, Yoshida K. Profiling of molecular pathways regulated by microRNA 601. Comput Biol Chem. 2009;33(6):429–433.
  • He Y, Meng X-M, Huang C, et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett. 2014;344(1):20–27.
  • Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX Loci by noncoding RNAs. Cell. 2007;129:1311–1323.
  • Huang W, Liu Z, Li Y, et al. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. J Cell Biochem. 2019;120(3):4121–4131.
  • Wu X, Cao N, Fenech M, et al. Role of Sirtuins in Maintenance of Genomic Stability: relevance to cancer and healthy aging. DNA Cell Biol. 2016;35(10):542–575.
  • Min L, Ji Y, Bakiri L, et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat Cell Biol. 2012;14(11):1203–1211.
  • Rüster B, Grace B, Seitz O, et al. Induction and detection of human mesenchymal stem cell migration in the 48-well reusable transwell assay. Stem Cells & Development. 2005;14(2):231–235.
  • Kim J, Aydemir TB, Jimenez-Rondan FR, et al. Deletion of metal transporter Zip14 (Slc39a14) produces skeletal muscle wasting, endotoxemia, Mef2c activation and induction of miR-675 and Hspb7. Sci Rep. 2020;10(1):4050.
  • Min C, Zhang A, Qin J. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer. Diagn Pathol. 2019;14(1):107.
  • Onishi M, Ochiya T, Tanaka Y. MicroRNA and liver cancer. Cancer Drug Resistance. 2020;3:385–400.
  • Song Y, He S, Zhuang J, et al. MicroRNA‑601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3. Mol Med Rep. 2019;19(3):2431–2439.
  • Du H, Wang X, Dong R, et al. miR-601 inhibits proliferation, migration and invasion of prostate cancer stem cells by targeting KRT5 to inactivate the Wnt signaling pathway. Int J Clin Exp Pathol. 2019;12(12):4361–4379.
  • Chen J, Zhang B, Wong N, et al. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res. 2011;71(12):4138–4149.
  • Portmann S, Fahrner R, Lechleiter A, et al. Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo. Mol Cancer Ther. 2013;12(4):499–508.
  • Cao W, Jin H, Zhang L, et al. Identification of miR-601 as a novel regulator in the development of pancreatic cancer. Biochem Biophys Res Commun. 2017;483(1):638–644.
  • Lu F, Zhou Q, Liu L, et al. A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients. Theranostics. 2020;10(2):484–497.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.